Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Sanda BURUIANĂ"'
Autor:
Lucia MAZUR-NICORICI, Victoria SADOVICI, Nicoleta CALUGARESCO, Snejana VETRILA, Sanda BURUIANĂ, Victor CIUPERCĂ, Minodora MAZUR
Publikováno v:
Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale, Vol 78, Iss 1, Pp 224-227 (2024)
Boala Castleman (BC) este o afecțiune foarte rară, care poate apărea la orice vârstă și care afectează 16:100000 pacienți/ani. BC se caracterizează prin simptome inflamatorii sistemice, limfadenopatie generalizată, proliferarea limfocitelor
Externí odkaz:
https://doaj.org/article/015ca84c60b34e2cb044a690598f6779
Publikováno v:
Psihologie, Vol 42, Iss 1,2023, Pp 47-55 (2023)
The given study focuses on the evaluation of the psycho-emotional well-being of patients with non-Hodgkin’s lymphomas (NHL) according to age, gender, living environment, morphological subtype, stage, primary tumor focus, Charlson comorbidities inde
Externí odkaz:
https://doaj.org/article/fa4092f3109b420187527b14fb8e5c15
Autor:
Sanda BURUIANĂ
Publikováno v:
Psihologie, Vol 37, Iss 3-4, Pp 52-59 (2020)
Limfoamele non-Hodgkin (LNH) includ un grup de tumori maligne ale ţesutului limfatic, constituind cele mai frecvente hemopatii maligne. Tratamentul modern al LNH permit obținerea remisiunii complete, prelungirea duratei de viață al pacienților.
Externí odkaz:
https://doaj.org/article/66d4606e0f244ffcbcc33f9941fb0a77
Autor:
Victor Tomacinschii, Maria Robu, Vasile Musteață, Irina Mocanu, Sanda Buruiană, Natalia Sporîș, Veronica Feghiu
Publikováno v:
Arta Medica, Vol 76, Iss 3 (2020)
Background: Acute promyelocytic leukemia is an acute myeloid leukemia that accounts approximately 10% of acute myeloid leukemia cases. Acute promyelocytic leukemias usually appears as a de novo finding. The occurrence of secondary acute promyelocytic
Externí odkaz:
https://doaj.org/article/de563c867770431db2b58054606afdee
Publikováno v:
Archives of the Balkan Medical Union, Vol 56, Iss 3, Pp 336-341 (2021)
Introduction. Indolent non-Hodgkin lymphoma (NHL) is a lymphoid tumor with increasing morbidity with age. The objective of the study was to assess the clinical and hematological features of indolent NHL in elderly patients. Material and methods. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9638a45c17a6b24115a568860007b6e
https://doi.org/10.31688/abmu.2021.56.3.07
https://doi.org/10.31688/abmu.2021.56.3.07
Publikováno v:
Archives of the Balkan Medical Union, Vol 55, Iss 3, Pp 418-423 (2020)
Introduction. Non-Hodgkin’s lymphoma (NHL) is a malignant cancer of the lymphatic system. Modern treatment of NHL allows patients to extend their lifespan, but at the same time somatic and psychological complications reduce the patients’ quality
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcf2ce6298f3a607feebc9c75ef6bfc3
https://umbalk.org/wp-content/uploads/2020/09/06.ASSESSING-THE-QUALITY-OF-LIFE-IN-PATIENTS.pdf
https://umbalk.org/wp-content/uploads/2020/09/06.ASSESSING-THE-QUALITY-OF-LIFE-IN-PATIENTS.pdf
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S42-(2021)
Objective Identification of hemostasis changes in patients with non-Hodgkin's lymphoma (NHL) and anticardiolipin antibodies (aCL). Methodology The study included 83 patients (men-34, women-49) with a mean age of 63.2 years, with NHL, investigated com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62188e2469caa1bd634733a27731a965
http://www.sciencedirect.com/science/article/pii/S2531137921011834
http://www.sciencedirect.com/science/article/pii/S2531137921011834
Autor:
Ivan Negara, Inga Chemencedji, Natalia Dobrovolschi, Natalia Sporis, Sanda Buruiana, Igor Vinogradov
Publikováno v:
Clinical Case Reports, Vol 12, Iss 4, Pp n/a-n/a (2024)
Key Clinical Message Identifying myeloid sarcoma in rare locations is a diagnostic challenge and requires careful evaluation. The optimal management of extramedullary disease requires further investigation, but tissue biopsy and a personalized approa
Externí odkaz:
https://doaj.org/article/4c35bbca5c59421eb154a8ee6cc0ec67
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S239
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f295c1554943c8c4580302068a484b06
https://doi.org/10.1016/s2152-2650(21)01504-4
https://doi.org/10.1016/s2152-2650(21)01504-4
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss, Pp 40-41 (2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e03a690a9d1ef335a0aaecbce5455e88
https://doi.org/10.1016/j.htct.2020.09.073
https://doi.org/10.1016/j.htct.2020.09.073